Guiling Li
4PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 19, 2024
Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study.Hanmei Lou, Hongbing Cai, Xin Huang
|Sep 22, 2022
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study.Jusheng An, Jie Tang, Benjamin X Li
|Jun 29, 2022
The Duration and Determinants of Anti-SARS-CoV-2 Immunoglobulin G in Cancer Patients with SARS-CoV-2 Infection: A Longitudinal Study.Yao Jiang, Yingchao Zhao, Guiling Li
|Jan 04, 2022
Duration of antibody responses following severe acute respiratory syndrome coronavirus 2 infection.Yao Jiang, Xiuqi Wei, Hui Wang
Pageof 1
